The Venture Capital Arm of Asia’s Leading Digital Agency, Integrated Management Systems, Announces Launch of Organic Platform in China
IMS Digital Ventures, the venture capital arm of Asia’s leading digital transformation agency, announces the launch of a social and content platform in China that will enable consumers to authenticate organic products thanks to blockchain technology
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191013005041/en/
OrgHive is a unique social and content platform where users can verify product authenticity, share content, and interact with individuals & brands (Photo: Business Wire)
The organic platform, OrgHive, empowers consumers to make the right purchasing decision thanks to a real-time database verification enhanced by blockchain technology
The inability of consumers to differentiate between authentic organic products, as well as lack of objective information available on the benefits of choosing organic, has proved a challenge for brands when engaging and selling to Chinese consumers. The organic platform overcomes these difficulties by enabling brands to effectively reach, engage, and convert audiences, thanks to a sophisticated AI algorithm that matches users with relevant content.
Apart from verifying product certification, users can also publish reviews, share content, follow brands, and build their own following on the platform.
“Chinese consumers spend significant time researching brands or products online and rely heavily on peer recommendations and crowdsourcing,” explains Anastasios Papadopoulos, CEO of Integrated Management Systems (IMS) and IMS Digital Ventures. “We’ve engineered the platform so that it takes into account the sophisticated Chinese consumer journey and provides an exciting ecosystem for audiences to interact and learn more about the benefits of wellness through organic lifestyle choices.”
Increased transparency and effective marketing will empower brands to drive their success in China thanks to OrgHive
The platform will also enable brands direct access to these audiences through thoughtful and relevant communications. For example, brands who wish to join the platform can create their own microsite from which they can grow their following, send push notifications, and drive audiences to e-commerce channels.
“This is a unique and exciting opportunity to share the future of the organic market in China,” states Anastasios Papadopoulos. “China’s surge in middle class consumers together with a consumer trend towards healthy lifestyle choices means there is a huge potential for market capture. For brands, we also provide a transparent and effective way to reach and convert customers in a fragmented and highly opaque digital landscape. By offering detailed insights to brands on platform analytics and user behaviour, we’re changing the rules of the game in China.”
About Anastasios Papadopoulos, CEO of Integrated Management Systems (IMS) Hong Kong
After completing his training in M&A at Skadden Arps, Anastasios founded Integrated Management Systems in 2016 and played a key strategic role in positioning the company as one of the leading Digital Transformation Agencies in Hong Kong.
Combining his experience in M&A and Tech, Anastasios founded IMS Digital Ventures, the innovation, incubation and investment arm of IMS and Hong Kong’s first corporate venturing firm that launches and invests in disruptive businesses with Asia’s largest corporations.
Anastasios read Law in France and in the UK and holds a Management degree from HEC Paris.
Visit LinkedIn profile: https://www.linkedin.com/in/anastasios-papadopoulos-aa400778/
About Integrated Management Systems (IMS) Hong Kong
Integrated Management Systems (IMS) is Hong Kong’s leading Digital Transformation Agency, offering technological solutions for data-driven strategies that transform businesses. IMS helps clients to build, manage, monitor, and analyse an integrated, cross-channel platform to provide a seamless customer experience, maximising ROI and market potential.
Services span marketing automation & CRM, digital transformation, data analytics, and omni-channel marketing strategies and execution.
Visit website: https://www.imanagesystems.com/
Follow us on Linked: https://www.linkedin.com/company/integrated-management-systems-ims-hk-ltd./
About IMS Digital Ventures (IMS DV)
IMS DV is the venture capital arm of Integrated Management Systems. By leveraging state-of-the-art technology, the team at IMS DV is able to navigate industry change and help companies adopt disruptive business models while sharing the risks and upside through corporate venturing.
Working with Asia’s most influential corporations and visionary entrepreneurs, IMS DV catapults visions into viable businesses through sustainable and resourceful digital solutions.
Visit website: http://www.imsdv.com/
Integrated Management Systems HK
Manuela Buerki, +852 3611 7840
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed13.12.2019 21:55:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under review and pending approval by the European Medicines Agency, for all eligible patients ages 12 and older in line with the potential future licensed indication. This expands the existing agreement which had already included access to current and future Vertex medicines for people in Ireland with CF of any age who: Have one of the specified mutations as included in the KALYDECO® marketing authorization (G551D, G551S, S549R, G1244E, S1251N, G1349D, S1255P, G178R or S549N) or Are homozygous for the F508del mutation or Are heterozygous for the F508del mutation and have a specified mutation (P67L, D579G, D1
CreditLens™ Solution Receives SOC 2 Attestation Report13.12.2019 18:17:00 EET | Press release
Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and availability controls standards. Built on the latest cloud-based technology, the CreditLens platform helps businesses digitally transform their commercial credit processes to make faster and better-informed decisions. It facilitates process automation and helps clients improve their efficiency, reduce errors, and streamline workflows. A SOC 2 report ensures that a company’s information security measures are in line with the unique parameters of today’s cloud requirements. The report addresses a service organization's controls that relate to operations and compliance, as outlined by the AICPA's Tru
CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible13.12.2019 14:47:00 EET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of adult patients with newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The Positive Opinion is supported by data from Part 1 of the Phase 3 CASSIOPEIA (MMY3006) study, published in The Lancet 3 in June 2019, and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting. Additional information about this study can be found at www.ClinicalTrials.gov (NCT02541383). “Today’s Opinion takes us a step closer to offering the first daratumumab combination regimen to transplant eligible patients, redefining treatment for those people newl
Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer13.12.2019 14:40:00 EET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).2 The CHMP’s Positive Opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the new use of apalutamide. The Positive Opinion is based on data from the Phase 3 TITAN study, which assessed the addition of apalutamide to ADT – the current standard of care in mHSPC – in a broad range of patients with mHSPC, regardless of disease volume, prior treatment with docetaxel or staging at initial diagnosis. The dual primary endpoints of the study were overall survival (OS) and radiographic progression-free survival (rPFS). Ap
German Player Karl Rupprec Wins 2019 Boyaa Poker Tournament Europe13.12.2019 12:24:00 EET | Press release
On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005109/en/ (Photo: Business Wire) Highlights of the BPT Europe 2019 final The BPT Europe 2019 Main Event began on December 8 at 2:00 p.m., Czech Republic time. After 9 hours of Texas Poker, players Ondrej Drozd from the Czech Republic and Karl Rupprec from Germany reached the last heads-up. In the end, Karl Rupprec, who started with half of his opponent's chips, reversed the situation with his two nines, winning the championship. Heads-up Highlights: Karl Rupprec pair 9 and Ondrej Drozd 2, 5. The flop was 2, Q, 9, so Karl Rupprec got three of a kind, and Ondrej Drozd got pair 2. Rupprec pretended
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by Italian Designed Architectural Lighting Brand for Motorized Luminaire with Smart Wireless Controls13.12.2019 12:00:00 EET | Press release
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architectural lighting brand formalighting Ltd. (“formalighting”), a global manufacturer of Italian designed architectural lighting systems and solutions for a new product line which offers motorized luminaire with smart wireless controls. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005009/en/ SunLike implemented in motion lamps (Photo: Business Wire) The SunLike COB LED packages have been adopted by formalighting for the new fixtures, Moto-Zero 40 Compasso and Moto-Zero 66 Zoom, in track mounted motorized spotlight range. In this sect
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom